Last reviewed · How we verify
NCT07460583
ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
NA trial testing Coronary CTA in Coronary Atherosclerosis Due to Calcified Coronary Lesion in 100 participants. Not yet recruiting.
31 October 2026
Quick facts
| Lead sponsor | Baylor Research Institute |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 100 |
| Start date | 28 April 2026 |
| Primary completion | 31 October 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Coronary CTA
Conditions studied
- Coronary Atherosclerosis Due to Calcified Coronary Lesion — all drugs for Coronary Atherosclerosis Due to Calcified Coronary Lesion →
Sponsor
Baylor Research Institute
Who can join
30 and older, any sex, with Coronary Atherosclerosis Due to Calcified Coronary Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
AI-Guided Coronary CT Angiography Screening in Former High-Intensity Athletes
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07460583
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coronary CTA
Trials testing the same drug.
- NCT05323227 — Lp(a) With CCTA Assessed Parameters and Clinical Outcomes · unknown
Other recruiting trials for Coronary Atherosclerosis Due to Calcified Coronary Lesion
Currently open trials in the same condition.
- NCT05796739 — Routine Versus As-Needed Stress Testing in Asymptomatic Patients With High-Risk Coronary Calcium · NA · recruiting
Other Baylor Research Institute trials
Trials by the same sponsor.
- NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
- NCT07547878 — Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · not yet recruiting
- NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
- NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting
- NCT07518238 — Hernia Abd Wall Recons - BDE vs Exparel · Phase 2 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07460583 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07460583.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing